C - Chemistry – Metallurgy – 07 – H
Patent
C - Chemistry, Metallurgy
07
H
C07H 21/04 (2006.01) A61K 31/7088 (2006.01) A61K 48/00 (2006.01) A61P 35/00 (2006.01) C07H 21/02 (2006.01) C12N 15/11 (2006.01) C12N 15/85 (2006.01)
Patent
CA 2345354
Compositions and methods are provided for modulating the expression of bcl-x. Antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding bcl-x are preferred. Methods of using these compounds for modulation of bcl-x expression and for treatment of diseases associated with expression of bcl-x are also provided. Methods of sensitizing cells to apoptotic stimuli are also provided.
L'invention concerne des compositions et des procédés permettant de moduler l'expression du gène bcl-x. On utilise de préférence des composés antisens, en particulier des oligonucléotides antisens, ciblés sur les acides nucléiques codant le gène bcl-x. L'invention concerne également des procédés relatifs à l'utilisation de ces composés, pour la modulation de l'expression du bcl-x et pour le traitement des maladies associées à l'expression dudit bcl-x. L'invention concerne en outre des procédés qui permettent de sensibiliser les cellules aux stimuli de l'apoptose.
Bennett C. Frank
Dean Nicholas M.
Monia Brett P.
Nickoloff Brian J.
Zhang Qingqing
Borden Ladner Gervais Llp
Isis Pharmaceuticals Inc.
LandOfFree
Antisense modulation of bcl-x expression does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antisense modulation of bcl-x expression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense modulation of bcl-x expression will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1670721